Computational redesign of a fluorogen activating protein with Rosetta.


Journal

PLoS computational biology
ISSN: 1553-7358
Titre abrégé: PLoS Comput Biol
Pays: United States
ID NLM: 101238922

Informations de publication

Date de publication:
11 2021
Historique:
received: 22 12 2020
accepted: 11 10 2021
revised: 18 11 2021
pubmed: 9 11 2021
medline: 18 12 2021
entrez: 8 11 2021
Statut: epublish

Résumé

The use of unnatural fluorogenic molecules widely expands the pallet of available genetically encoded fluorescent imaging tools through the design of fluorogen activating proteins (FAPs). While there is already a handful of such probes available, each of them went through laborious cycles of in vitro screening and selection. Computational modeling approaches are evolving incredibly fast right now and are demonstrating great results in many applications, including de novo protein design. It suggests that the easier task of fine-tuning the fluorogen-binding properties of an already functional protein in silico should be readily achievable. To test this hypothesis, we used Rosetta for computational ligand docking followed by protein binding pocket redesign to further improve the previously described FAP DiB1 that is capable of binding to a BODIPY-like dye M739. Despite an inaccurate initial docking of the chromophore, the incorporated mutations nevertheless improved multiple photophysical parameters as well as the overall performance of the tag. The designed protein, DiB-RM, shows higher brightness, localization precision, and apparent photostability in protein-PAINT super-resolution imaging compared to its parental variant DiB1. Moreover, DiB-RM can be cleaved to obtain an efficient split system with enhanced performance compared to a parental DiB-split system. The possible reasons for the inaccurate ligand binding pose prediction and its consequence on the outcome of the design experiment are further discussed.

Identifiants

pubmed: 34748541
doi: 10.1371/journal.pcbi.1009555
pii: PCOMPBIOL-D-20-02300
pmc: PMC8601599
doi:

Substances chimiques

4,4-difluoro-4-bora-3a,4a-diaza-s-indacene 0
Boron Compounds 0
Fluorescent Dyes 0
Luminescent Proteins 0
Recombinant Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1009555

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM099842
Pays : United States
Organisme : NIAID NIH HHS
ID : R56 AI110750
Pays : United States
Organisme : NIH HHS
ID : S10 OD023680
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):497-502
pubmed: 26711992
Mol Biosyst. 2012 Aug;8(8):2036-40
pubmed: 22692102
PLoS One. 2008;3(11):e3647
pubmed: 18985154
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
PLoS One. 2009;4(5):e5553
pubmed: 19436741
Acta Crystallogr D Biol Crystallogr. 2010 Dec;66(Pt 12):1308-15
pubmed: 21123871
PLoS One. 2011;6(5):e19230
pubmed: 21603656
Science. 2009 May 8;324(5928):804-7
pubmed: 19423828
FEBS Lett. 2006 Sep 4;580(20):4877-83
pubmed: 16920109
Sci Rep. 2020 Jul 6;10(1):11049
pubmed: 32632329
J Am Chem Soc. 2008 Sep 24;130(38):12620-1
pubmed: 18761447
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Acc Chem Res. 2012 Feb 21;45(2):171-81
pubmed: 21861536
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
pubmed: 15299926
Methods Enzymol. 2011;487:545-74
pubmed: 21187238
J Struct Biol. 2014 Feb;185(2):193-202
pubmed: 23962892
FEBS Lett. 2004 Mar 26;562(1-3):183-8
pubmed: 15044022
Prog Mol Biol Transl Sci. 2013;113:1-34
pubmed: 23244787
Nat Biotechnol. 2008 Feb;26(2):235-40
pubmed: 18157118
Biotechniques. 2011 Jul;51(1):55-6
pubmed: 21781054
Bioorg Khim. 2009 Nov-Dec;35(6):726-43
pubmed: 20208574
BMC Struct Biol. 2012 Aug 02;12:18
pubmed: 22857400
Biochemistry. 1994 Jan 11;33(1):2-9
pubmed: 8286340
Cell. 2013 Jun 20;153(7):1602-11
pubmed: 23768684
Nat Biotechnol. 2002 Jan;20(1):87-90
pubmed: 11753368
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
Nature. 2018 Sep;561(7724):485-491
pubmed: 30209393
ACS Chem Biol. 2020 Sep 18;15(9):2456-2465
pubmed: 32809793
Chemistry. 2014 Oct 6;20(41):13234-41
pubmed: 25171432
Nat Biotechnol. 2011 Jul 17;29(8):757-61
pubmed: 21765402
J Cheminform. 2015 Sep 30;7:47
pubmed: 26473018
Methods Mol Biol. 2011;729:167-81
pubmed: 21365490
Chem Sci. 2017 Oct 1;8(10):7138-7142
pubmed: 29147545
Methods Mol Biol. 2016;1414:47-62
pubmed: 27094285
PLoS Comput Biol. 2015 Jul 06;11(7):e1004300
pubmed: 26147100
PLoS One. 2013;8(4):e59004
pubmed: 23565140
Int J Mol Sci. 2018 Nov 28;19(12):
pubmed: 30486502
Angew Chem Int Ed Engl. 2020 Oct 5;59(41):17917-17923
pubmed: 32568417
Trends Plant Sci. 2000 Aug;5(8):337-42
pubmed: 10908878
Nat Biotechnol. 2007 Apr;25(4):443-5
pubmed: 17351616

Auteurs

Nina G Bozhanova (NG)

Department of Chemistry and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, United States of America.

Joel M Harp (JM)

Department of Biochemistry, School of Medicine, Vanderbilt University, Nashville, Tennessee, United States of America.

Brian J Bender (BJ)

Department of Pharmacology and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, United States of America.

Alexey S Gavrikov (AS)

Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.

Dmitry A Gorbachev (DA)

Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.

Mikhail S Baranov (MS)

Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Pirogov Russian National Research Medical University, Moscow, Russia.

Christina B Mercado (CB)

Department of Chemistry and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, United States of America.

Xuan Zhang (X)

Department of Chemistry and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, United States of America.

Konstantin A Lukyanov (KA)

Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.

Alexander S Mishin (AS)

Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.

Jens Meiler (J)

Department of Chemistry and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, United States of America.
Institute for Drug Discovery, Leipzig University, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH